Success in the development of a gamma-tubulin specific inhibitor

January 20, 2016, University of Tsukuba
Success in the development of a γ-tubulin specific inhibitor
The g-tubulin-specific inhibitor gatastatin (right) developed by the research group from Glaziovianin A (AG1, left)

Microtubules, one component of a cell's skeleton, are hollow tubes formed from the polymerization of α- and β-tubulin, which are themselves important structural proteins of the mitotic spindle that equally separates chromosomes during cell division. As such, several α/β-tubulin inhibitory agents are used as therapeutic drugs against cancer cells, which are undergoing vigorous cell division. However, microtubules perform important work even outside of cell division, and normal cells not undergoing division can be harmed as well, so the side effects of such treatments have become problematic. A wide variety of research has shown that γ-tubulin activates during cell division and that it is overexpressed in a portion of cancer cells, so it holds potential as a target protein for new anticancer agents with few side effects. Despite this research, no specific inhibitors have thus far been discovered.

University of Tsukuba Faculty of Life and Environmental Sciences Associate Professor Takeo Usui and Researcher Takumi Chinen, and University of Tsukuba Faculty of Pure and Applied Sciences Professor Hideo Kigoshi, in joint research with Heidelberg University, Okayama University, Tokyo University of Pharmacy and Life Sciences, and RIKEN have synthesized and developed the α/β-tubulin inhibitors glaziovianin A and plinabulin, advancing the development of compounds that exhibit γ-tubulin inhibitory activity, and have succeeded in developing the γ-tubulin specific inhibitor gatastatin.

Furthermore, using gatastatin their research has shed light on the fact that γ-tubulin function is important in microtubule function in the late stages of . The results of these studies provide knowledge linking to analyses of intracellular γ-tubulin function as well as the development of new anticancer agents.

Explore further: Molecular motor grows cell's microtubules

More information: Takumi Chinen et al. The γ-tubulin-specific inhibitor gatastatin reveals temporal requirements of microtubule nucleation during the cell cycle, Nature Communications (2015). DOI: 10.1038/ncomms9722

Related Stories

Molecular motor grows cell's microtubules

October 26, 2015

Motor proteins that pause at the ends of microtubules and produce pushing forces can also stimulate their growth, according to researchers at Penn State. The proteins' function could be a critical component in understanding ...

Thwarting abnormal neural development with a new mutation

January 18, 2016

Researchers at the RIKEN Brain Science Institute in Japan have discovered how to reverse the abnormal axonal development characteristic of CFEOM3, a congenital disease that affects the muscles that control eye movements. ...

Molecular machine, not assembly line, assembles microtubules

August 20, 2015

When they think about how cells put together the molecules that make life work, biologists have tended to think of assembly lines: Add A to B, tack on C, and so on. But the reality might be more like a molecular version of ...

Cell architecture: Finding common ground

October 16, 2014

When it comes to cellular architecture, function follows form. Plant cells contain a dynamic cytoskeleton which is responsible for directing cell growth, development, movement, and division. So over time, changes in the cytoskeleton ...

Recommended for you


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.